DAVID W GRYSKA Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DAVID W GRYSKA.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DAVID W GRYSKA. DAVID W GRYSKA is Executive Vice President, CFO in INCYTE CORP ($INCY) and Director in PDL BIOPHARMA, INC. ($PDLI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in COTHERIX INC ($CTRX) and Director in AERIE PHARMACEUTICALS INC ($AERI) and Director in GW PHARMACEUTICALS PLC ($GWPH).

Latest Insider Trading Transactions of DAVID W GRYSKA

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AERI, CTRX, GWPH, INCY, PDLI, SGEN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 18 2021	SGEN	Seagen Inc.	GRYSKA DAVID W	Director	Option Exercise	A	147.50	3,462	510,645	3,462
May 18 2021	SGEN	Seagen Inc.	GRYSKA DAVID W	Director	Grant	A	0.00	1,402	0	46,250	44.8 K to 46.3 K (+3.13 %)
Feb 24 2021	GWPH	GW PHARMACEUTICALS ...	GRYSKA DAVID W	Director	Option Exercise	A	0.00	22,464	31	22,464
Dec 31 2020	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Sell	S	2.74	20,000	54,800	1,387	21.4 K to 1.4 K (-93.51 %)
Dec 17 2020	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Sell	S	2.68	75,000	201,000	21,387	96.4 K to 21.4 K (-77.81 %)
Dec 17 2020	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Sell	S	2.68	75,000	201,000	21,387	96.4 K to 21.4 K (-77.81 %)
Dec 04 2020	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Sell	S	2.52	75,000	189,000	30,337	105.3 K to 30.3 K (-71.20 %)
Dec 04 2020	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Sell	S	2.52	75,000	189,000	30,337	105.3 K to 30.3 K (-71.20 %)
Nov 23 2020	SGEN	Seagen Inc.	GRYSKA DAVID W	Director	Option Exercise	M	19.02	7,871	149,706	0
Nov 23 2020	SGEN	Seagen Inc.	GRYSKA DAVID W	Director	Option Exercise	M	19.02	7,129	135,594	7,871
Nov 23 2020	SGEN	Seagen Inc.	GRYSKA DAVID W	Director	Sell	S	173.25	7,871	1,363,651	44,848	52.7 K to 44.8 K (-14.93 %)
Nov 23 2020	SGEN	Seagen Inc.	GRYSKA DAVID W	Director	Buy	M	19.02	7,871	149,706	52,719	44.8 K to 52.7 K (+17.55 %)
Nov 23 2020	SGEN	Seagen Inc.	GRYSKA DAVID W	Director	Sell	S	174.20	7,129	1,241,872	44,848	52 K to 44.8 K (-13.72 %)
Nov 23 2020	SGEN	Seagen Inc.	GRYSKA DAVID W	Director	Buy	M	19.02	7,129	135,594	51,977	44.8 K to 52 K (+15.90 %)
Nov 19 2020	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Sell	S	2.39	50,000	119,500	95,337	145.3 K to 95.3 K (-34.40 %)
Nov 19 2020	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Sell	S	2.40	100,000	240,000	145,337	245.3 K to 145.3 K (-40.76 %)
Nov 06 2020	SGEN	Seagen Inc.	GRYSKA DAVID W	Director	Sell	S	180.60	4,500	812,699	44,848	49.3 K to 44.8 K (-9.12 %)
Sep 16 2020	GWPH	GW PHARMACEUTICALS ...	GRYSKA DAVID W	Director	Option Exercise	A	0.00	35,208	60	35,208
Aug 24 2020	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Option Exercise	A	3.63	118,671	430,776	118,671
Aug 24 2020	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Grant	A	0.00	25,826	0	245,337	219.5 K to 245.3 K (+11.77 %)
Jun 29 2020	AERI	AERIE PHARMACEUTIC ...	GRYSKA DAVID W	Director	Option Exercise	A	13.27	7,800	103,506	7,800
Jun 29 2020	AERI	AERIE PHARMACEUTIC ...	GRYSKA DAVID W	Director	Grant	A	0.00	1,750	0	3,500	1.8 K to 3.5 K (+100.00 %)
May 19 2020	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	A	160.33	3,171	508,406	3,171
May 19 2020	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Grant	A	0.00	1,335	0	49,348	48 K to 49.3 K (+2.78 %)
Oct 03 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	M	19.02	2,500	47,550	15,000
Oct 03 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	M	12.76	2,500	31,900	0
Oct 03 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Sell	S	84.85	2,500	212,125	48,013	50.5 K to 48 K (-4.95 %)
Oct 03 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Buy	M	12.76	2,500	31,900	50,513	48 K to 50.5 K (+5.21 %)
Oct 03 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Sell	S	85.33	2,500	213,325	48,013	50.5 K to 48 K (-4.95 %)
Oct 03 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Buy	M	19.02	2,500	47,550	50,513	48 K to 50.5 K (+5.21 %)
Jul 19 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	M	12.76	5,000	63,800	2,500
Jul 19 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Sell	S	75.00	5,000	375,000	48,013	53 K to 48 K (-9.43 %)
Jul 19 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Buy	M	12.76	5,000	63,800	53,013	48 K to 53 K (+10.41 %)
Jun 24 2019	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Option Exercise	A	3.00	126,050	378,150	126,050
Jun 24 2019	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Option Exercise	A	3.00	126,050	378,150	126,050
May 23 2019	AERI	AERIE PHARMACEUTIC ...	GRYSKA DAVID W	Director	Option Exercise	A	39.44	7,800	307,632	7,800
May 23 2019	AERI	AERIE PHARMACEUTIC ...	GRYSKA DAVID W	Director	Grant	A	0.00	1,750	0	1,750	0 to 1.8 K
May 22 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	A	64.38	7,038	453,106	7,038
May 22 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Grant	A	0.00	2,963	0	48,013	45.1 K to 48 K (+6.58 %)
May 22 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	A	64.38	7,038	453,106	7,038
May 22 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Grant	A	0.00	2,963	0	48,013	45.1 K to 48 K (+6.58 %)
Apr 03 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	M	12.76	5,000	63,800	7,500
Apr 03 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Sell	S	74.01	206	15,246	45,050	45.3 K to 45.1 K (-0.46 %)
Apr 03 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Sell	S	73.38	4,794	351,784	45,256	50.1 K to 45.3 K (-9.58 %)
Apr 03 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Buy	M	12.76	5,000	63,800	50,050	45.1 K to 50.1 K (+11.10 %)
Jan 10 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	M	12.76	5,000	63,800	12,500
Jan 10 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Sell	S	65.04	5,000	325,200	45,050	50.1 K to 45.1 K (-9.99 %)
Jan 10 2019	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Buy	M	12.76	5,000	63,800	50,050	45.1 K to 50.1 K (+11.10 %)
Sep 12 2018	AERI	AERIE PHARMACEUTIC ...	GRYSKA DAVID W	Director	Option Exercise	A	58.35	25,000	1,458,750	25,000
Jul 18 2018	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Payment of Exercise	F	70.19	455	31,936	10,235	10.7 K to 10.2 K (-4.26 %)
Jul 05 2018	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	68.62	22,772	1,562,615	22,772
Jul 05 2018	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Payment of Exercise	F	68.28	280	19,118	10,690	11 K to 10.7 K (-2.55 %)
May 22 2018	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	A	56.77	9,260	525,690	9,260
May 22 2018	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Grant	A	0.00	3,700	0	45,050	41.4 K to 45.1 K (+8.95 %)
Feb 22 2018	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Sell	S	85.56	1,952	167,013	10,970	12.9 K to 11 K (-15.11 %)
Feb 22 2018	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Payment of Exercise	F	86.03	1,070	92,052	12,922	14 K to 12.9 K (-7.65 %)
Jan 25 2018	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	94.63	12,128	1,147,673	12,128
Jan 09 2018	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	M	83.83	6,760	566,691	11,735
Jan 09 2018	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Sell	S	98.87	6,760	668,361	13,992	20.8 K to 14 K (-32.58 %)
Jan 09 2018	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Buy	M	83.83	6,760	566,691	20,752	14 K to 20.8 K (+48.31 %)
Nov 03 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Sell	S	105.63	3,915	413,541	13,992	17.9 K to 14 K (-21.86 %)
Nov 03 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Payment of Exercise	F	107.96	3,913	422,447	17,907	21.8 K to 17.9 K (-17.93 %)
Sep 15 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Payment of Exercise	F	123.15	712	87,683	21,820	22.5 K to 21.8 K (-3.16 %)
Jul 07 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	128.34	779	99,977	779
Jul 07 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	128.34	11,349	1,456,531	11,349
Jul 07 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Grant	A	0.00	3,517	0	22,532	19 K to 22.5 K (+18.50 %)
Jul 05 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	M	73.21	599	43,853	3,591
Jul 05 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Sell	S	129.74	599	77,714	19,015	19.6 K to 19 K (-3.05 %)
Jul 05 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Buy	M	73.21	599	43,853	19,614	19 K to 19.6 K (+3.15 %)
Jun 14 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	M	73.21	16,756	1,226,707	4,190
Jun 14 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Sell	S	116.60	16,756	1,953,750	19,015	35.8 K to 19 K (-46.84 %)
Jun 14 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Buy	M	73.21	16,756	1,226,707	35,771	19 K to 35.8 K (+88.12 %)
Jun 12 2017	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Grant	A	2.47	60,729	150,001	165,163	104.4 K to 165.2 K (+58.15 %)
May 23 2017	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	A	66.60	9,260	616,716	9,260
May 23 2017	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Grant	A	0.00	3,700	0	41,350	37.7 K to 41.4 K (+9.83 %)
May 02 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	M	67.06	1,389	93,146	9,725
May 02 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Sell	S	124.26	1,389	172,597	19,015	20.4 K to 19 K (-6.81 %)
May 02 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Buy	M	67.06	1,389	93,146	20,404	19 K to 20.4 K (+7.30 %)
Apr 11 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	M	67.06	39,789	2,668,250	11,114
Apr 11 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	M	67.06	1,739	116,617	2,734
Apr 11 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Sell	S	138.00	39,789	5,490,882	19,015	58.8 K to 19 K (-67.66 %)
Apr 11 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Sell	S	138.00	1,739	239,982	58,804	60.5 K to 58.8 K (-2.87 %)
Apr 11 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Buy	M	67.06	39,789	2,668,250	60,543	20.8 K to 60.5 K (+191.72 %)
Apr 11 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Buy	M	67.06	1,739	116,617	20,754	19 K to 20.8 K (+9.15 %)
Jan 19 2017	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	113.64	19,091	2,169,501	19,091
Sep 08 2016	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	M	10.20	10,000	102,000	0
Sep 08 2016	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Buy	M	10.20	10,000	102,000	37,650	27.7 K to 37.7 K (+36.17 %)
Jul 19 2016	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	83.83	596	49,963	596
Jul 19 2016	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	83.83	18,495	1,550,436	18,495
Jul 19 2016	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Grant	A	0.00	5,555	0	19,015	13.5 K to 19 K (+41.27 %)
Jun 03 2016	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Grant	A	3.52	71,023	250,001	104,434	33.4 K to 104.4 K (+212.57 %)
May 24 2016	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	A	38.82	9,260	359,473	9,260
May 24 2016	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Grant	A	0.00	3,700	0	27,650	24 K to 27.7 K (+15.45 %)
Jan 08 2016	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	95.76	1,044	99,973	1,044
Jan 08 2016	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	95.76	2,995	286,801	2,995
Jan 08 2016	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	95.76	1,108	106,102	1,108
Jan 08 2016	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Option Exercise	A	95.76	17,676	1,692,654	17,676
Jan 08 2016	INCY	INCYTE CORP	GRYSKA DAVID W	Executive Vice Pres ...	Grant	A	0.00	2,610	0	13,460	10.9 K to 13.5 K (+24.06 %)
Nov 05 2015	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Sell	S	43.57	10,000	435,737	23,950	34 K to 24 K (-29.46 %)
May 29 2015	PDLI	PDL BIOPHARMA, INC ...	GRYSKA DAVID W	Director	Grant	A	6.80	22,059	150,001	33,411	11.4 K to 33.4 K (+194.32 %)
May 19 2015	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	A	39.94	9,260	369,844	9,260
May 19 2015	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Grant	A	0.00	3,700	0	33,950	30.3 K to 34 K (+12.23 %)
Apr 14 2015	AERI	AERIE PHARMACEUTIC ...	GRYSKA DAVID W	Director	Option Exercise	A	32.30	10,000	323,000	10,000
Apr 14 2015	AERI	AERIE PHARMACEUTIC ...	GRYSKA DAVID W	Director	Grant	A	0.00	1,700	0	1,700	0 to 1.7 K
Apr 10 2015	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Option Exercise	M	8.38	5,000	41,900	0
Apr 10 2015	SGEN	SEATTLE GENETICS I ...	GRYSKA DAVID W	Director	Buy	M	8.38	5,000	41,900	30,250	25.3 K to 30.3 K (+19.80 %)
May 26 2006	CTRX	COTHERIX INC	GRYSKA DAVID W	Director	Option Exercise	A	7.69	6,060	46,601	6,060
May 20 2005	CTRX	COTHERIX INC	GRYSKA DAVID W	Director	Option Exercise	A	7.13	6,060	43,208	6,060
Dec 29 2004	CTRX	COTHERIX INC	GRYSKA DAVID W	Director	Option Exercise	A	9.79	18,180	177,982	18,180

Page: 1